Free Design Audit Available - Click Here for Details

SurGenTec wins FDA nod for hydrophilic synthetic bone graft

SurGenTec announced today that it received FDA 510(k) clearance for its OsteoFlo HydroPutty synthetic bone graft.

OsteoFlo HydroPutty follows the company’s OsteoFlo NanoPutty, which received FDA clearance in 2020. SurGenTec said that, along with clearance, it can report the first implantations of the new graft as well.

The new bone graft offers what the company calls a “significant advancement” in bone graft technology. It features a combination of proprietary hydrophilic carriers designed to absorb fluids like bone marrow aspirate, blood or saline. This formulation turns to putty and offers superior handling characteristics, plus a resorption profile optimized for bone growth.

Sign up for Blog Updates